CD44 and cancer: CD44, through alternative splicing and interaction with the tumor microenvironment, is not merely a marker of cancer-initiating cells but also actively contributes to tumor progression by facilitating cell migration, niche preparation, epithelial-mesenchymal transition, and resistance to apoptosis.